Plasticity-related gene-1 inhibits lysophosphatidic acid-induced vascular smooth muscle cell migration and proliferation and prevents neointima formation

American Journal of Physiology - Cell Physiology

Volumn 303, Issue 10, 2012, Pages

  Gaaya, Amira ^a,b   Poirier, Odette ^a,b   Mougenot, Nathalie ^a,b   Hery, Tiphaine ^a,b   Atassi, Fabrice ^a,b   Marchand, Alexandre ^a,b   Saulnier Blache, Jean Sébastien ^c,d   Amour, Julien ^a,e   Vogt, Johannes ^f   Lompré, Anne Marie ^a,b   Soubrier, Florent ^a,b   Nadaud, Sophie ^a,b  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c Université de Toulouse   (France)

^d UNIVERSITÉ PAUL SABATIER   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Lipid phosphate phosphatase; Lysophosphatidate; MAPK; Neointimal formation; Phenotypic modulation

Indexed keywords

BETA GALACTOSIDASE; HISTIDINE; LYSOPHOSPHATIDIC ACID; PHOSPHATASE; PLATELET DERIVED GROWTH FACTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; MALE; NEOINTIMA; NONHUMAN; PLASTICITY RELATED GENE 1; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TUNICA MEDIA; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; CALMODULIN-BINDING PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; LYSOPHOSPHOLIPIDS; MALE; MUSCLE, SMOOTH, VASCULAR; NEOINTIMA; PHOSPHORIC MONOESTER HYDROLASES; RATS; RATS, WISTAR;

ADENOVIRIDAE; RATTUS;

EID: 84869216727     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00051.2012     Document Type: Article

References (42)

1. Ai S, Kuzuya M, Koike T, Asai T, Kanda S, Maeda K, Shibata T, Iguchi A. Rho-Rho kinase is involved in smooth muscle cell migration through myosin light chain phosphorylation-dependent and independent pathways. Atherosclerosis 155: 321-327, 2001.
2. Aoki J, Inoue A, Okudaira S. Two pathways for lysophosphatidic acid production. Biochim Biophys Acta 1781: 513-518, 2008.
3. Blaschke F, Bruemmer D, Law RE. Egr-1 is a major vascular pathogenic transcription factor in atherosclerosis and restenosis. Rev Endocr Metab Disord 5: 249-254, 2004.
4. Brauer AU, Nitsch R. Plasticity-related genes (PRGs/LRPs): a brainspecific class of lysophospholipid-modifying proteins. Biochim Biophys Acta 1781: 595-600, 2008.
5. Brauer AU, Savaskan NE, Kuhn H, Prehn S, Ninnemann O, Nitsch R. A new phospholipid phosphatase, PRG-1, is involved in axon growth and regenerative sprouting. Nat Neurosci 6: 572-578, 2003.
6. Brindley DN, Pilquil C. Lipid phosphate phosphatases and signaling. J Lipid Res 50, Suppl: S225-230, 2009.
7. Browning CL, Culberson DE, Aragon IV, Fillmore RA, Croissant JD, Schwartz RJ, Zimmer WE. The developmentally regulated expression of serum response factor plays a key role in the control of smooth musclespecific genes. Dev Biol 194: 18-37, 1998.
8. Cui MZ, Laag E, Sun L, Tan M, Zhao G, Xu X. Lysophosphatidic acid induces early growth response gene 1 expression in vascular smooth muscle cells: CRE and SRE mediate the transcription. Arterioscler Thromb Vasc Biol 26: 1029-1035, 2006.
9. Dupuis M, Soubrier F, Brocheriou I, Raoux S, Haloui M, Louedec L, Michel JB, Nadaud S. Profiling of aortic smooth muscle cell gene expression in response to chronic inhibition of nitric oxide synthase in rats. Circulation 110: 867-873, 2004.
10. Escalante-Alcalde D, Hernandez L, Le Stunff H, Maeda R, Lee Gang CHS Jr, Sciorra VA, Daar I, Spiegel S, Morris AJ, Stewart CL. The lipid phosphatase LPP3 regulates extra-embryonic vasculogenesis and axis patterning. Development 130: 4623-4637, 2003.
11. Ezan J, Leroux L, Barandon L, Dufourcq P, Jaspard B, Moreau C, Allieres C, Daret D, Couffinhal T, Duplaa C. FrzA/sFRP-1, a secreted antagonist of the Wnt-Frizzled pathway, controls vascular cell proliferation in vitro and in vivo. Cardiovasc Res 63: 731-738, 2004.
12. Fahrenholz M, Real R, Kuken A, Saxena A, Orzechowski HD. Single low-dose administration of pharmacological inhibitor of mitogen-activated ERK kinase to the adventitia of the injured rat carotid artery suppresses neointima formation and inhibits nuclear ERK signaling. Eur J Pharmacol 617: 90-96, 2009.
13. Hayashi K, Takahashi M, Nishida W, Yoshida K, Ohkawa Y, Kitabatake A, Aoki J, Arai H, Sobue K. Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids. Circ Res 89: 251-258, 2001.
14. Hu Y, Cheng L, Hochleitner BW, Xu Q. Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury. Arterioscler Thromb Vasc Biol 17: 2808-2816, 1997.
15. Izumi Y, Kim S, Namba M, Yasumoto H, Miyazaki H, Hoshiga M, Kaneda Y, Morishita R, Zhan Y, Iwao H. Gene transfer of dominantnegative mutants of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase prevents neointimal formation in balloon-injured rat artery. Circ Res 88: 1120-1126, 2001.
16. Kaneyuki U, Ueda S, Yamagishi S, Kato S, Fujimura T, Shibata R, Hayashida A, Yoshimura J, Kojiro M, Oshima K, Okuda S. Pitavastatin inhibits lysophosphatidic acid-induced proliferation and monocyte chemoattractant protein-1 expression in aortic smooth muscle cells by suppressing Rac-1-mediated reactive oxygen species generation. Vascul Pharmacol 46: 286-292, 2007.
17. Kawai-Kowase K, Owens GK. Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am J Physiol Cell Physiol 292: C59-C69, 2007.
18. Kim J, Keys JR, Eckhart AD. Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq. Cell Signal 18: 1695-1701, 2006.
19. 2-ATPase gene transfer reduces vascular smooth muscle cell proliferation and neointima formation in the rat. Circ Res 97: 488-495, 2005.
20. Long JS, Yokoyama K, Tigyi G, Pyne NJ, Pyne S. Lipid phosphate phosphatase-1 regulates lysophosphatidic acid-and platelet-derivedgrowth-factor-induced cell migration. Biochem J 394: 495-500, 2006.
21. McDermott MI, Sigal YJ, Sciorra VA, Morris AJ. Is PRG-1 a new lipid phosphatase? Nat Neurosci 7: 789; author reply 789-790, 2004.
22. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75: 487-517, 1995.
23. Panchatcharam M, Miriyala S, Yang F, Rojas M, End C, Vallant C, Dong A, Lynch K, Chun J, Morris AJ, Smyth SS. Lysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure. Circ Res 103: 662-670, 2008.
24. Pilquil C, Dewald J, Cherney A, Gorshkova I, Tigyi G, English D, Natarajan V, Brindley DN. Lipid phosphate phosphatase-1 regulates lysophosphatidate-induced fibroblast migration by controlling phospholipase D2-dependent phosphatidate generation. J Biol Chem 281: 38418-38429, 2006.
25. Siess W, Tigyi G. Thrombogenic and atherogenic activities of lysophosphatidic acid. J Cell Biochem 92: 1086-1094, 2004.
26. Siess W, Zangl KJ, Essler M, Bauer M, Brandl R, Corrinth C, Bittman R, Tigyi G, Aepfelbacher M. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci USA 96: 6931-6936, 1999.
27. Sigal YJ, McDermott MI, Morris AJ. Integral membrane lipid phosphatases/ phosphotransferases: common structure and diverse functions. Biochem J 387: 281-293, 2005.
28. Smyth SS, Cheng HY, Miriyala S, Panchatcharam M, Morris AJ. Roles of lysophosphatidic acid in cardiovascular physiology and disease. Biochim Biophys Acta 1781: 563-570, 2008.
29. Subramanian P, Karshovska E, Reinhard P, Megens RT, Zhou Z, Akhtar S, Schumann U, Li X, van Zandvoort M, Ludin C, Weber C, Schober A. Lysophosphatidic acid receptors LPA1 and LPA3 promote CXCL12-mediated smooth muscle progenitor cell recruitment in neointima formation. Circ Res 107: 96-105, 2010.
30. Tokumitsu H, Hatano N, Tsuchiya M, Yurimoto S, Fujimoto T, Ohara N, Kobayashi R, Sakagami H. Identification and characterization of PRG-1 as a neuronal calmodulin-binding protein. Biochem J 431: 81-91, 2010
31. Tokumura A, Iimori M, Nishioka Y, Kitahara M, Sakashita M, Tanaka S. Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. Am J Physiol Cell Physiol 267: C204-C210, 1994.
32. Tomsig JL, Snyder AH, Berdyshev EV, Skobeleva A, Mataya C, Natarajan V, Brindley DN, Lynch KR. Lipid phosphate phosphohydrolase type 1 (LPP1) degrades extracellular lysophosphatidic acid in vivo. Biochem J 419: 611-618, 2009.
33. Trimbuch T, Beed P, Vogt J, Schuchmann S, Maier N, Kintscher M, Breustedt J, Schuelke M, Streu N, Kieselmann O, Brunk I, Laube G, Strauss U, Battefeld A, Wende H, Birchmeier C, Wiese S, Sendtner M, Kawabe H, Kishimoto-Suga M, Brose N, Baumgart J, Geist B, Aoki J, Savaskan NE, Brauer AU, Chun J, Ninnemann O, Schmitz D, Nitsch R. Synaptic PRG-1 modulates excitatory transmission via lipid phosphatemediated signaling. Cell 138: 1222-1235, 2009.
34. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001.
35. Vallot O, Combettes L, Jourdon P, Inamo J, Marty I, Claret M, Lompre AM. Intracellular Ca(2) handling in vascular smooth muscle cells is affected by proliferation. Arterioscler Thromb Vasc Biol 20: 1225-1235, 2000.
36. Xu YJ, Aziz OA, Bhugra P, Arneja AS, Mendis MR, Dhalla NS. Potential role of lysophosphatidic acid in hypertension and atherosclerosis. Can J Cardiol 19: 1525-1536, 2003.
37. Xu YJ, Ouk Kim S, Liao DF, Katz S, Pelech SL. Stimulation of 90-and 70-kDa ribosomal protein S6 kinases by arginine vasopressin and lysophosphatidic acid in rat cardiomyocytes. Biochem Pharmacol 59: 1163-1171, 2000.
38. Xu YJ, Saini HK, Cheema SK, Dhalla NS. Mechanisms of lysophosphatidic acid-induced increase in intracellular calcium in vascular smooth muscle cells. Cell Calcium 38: 569-579, 2005.
39. Yoshida K, Nishida W, Hayashi K, Ohkawa Y, Ogawa A, Aoki J, Arai H, Sobue K. Vascular remodeling induced by naturally occurring unsaturated lysophosphatidic acid in vivo. Circulation 108: 1746-1752, 2003.
40. Yoshida T, Owens GK. Molecular determinants of vascular smooth muscle cell diversity. Circ Res 96: 280-291, 2005.
41. Zhang C, Baker DL, Yasuda S, Makarova N, Balazs L, Johnson LR, Marathe GK, McIntyre TM, Xu Y, Prestwich GD, Byun HS, Bittman R, Tigyi G. Lysophosphatidic acid induces neointima formation through PPARgamma activation. J Exp Med 199: 763-774, 2004.
42. Zhang QX, Pilquil CS, Dewald J, Berthiaume LG, Brindley DN. Identification of structurally important domains of lipid phosphate phosphatase-1: implications for its sites of action. Biochem J 345: 181-184, 2000